企業プロフィール
Immunome 株価・ニュース・カタリスト
- ティッカー:
- IMNM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
28.08 USD (-5.85%)
終値
最終更新: 2026年8月20日
2.19B USD
時価総額
株価変動の要因
As of Aug 20, 2026, IMNM closed down 5.85% at $28.08. No new same-company headline was identified in the current news window.
企業概要
事業概要
Immunome is a biotechnology company focused on antibody discovery and oncology, with a platform that seeks to translate immune recognition into therapeutic programs. Its story is about building value from discovery engines and targeted cancer biology.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Immunome sits in specialty biotechnology.
ビジネスモデルの特徴
The company depends on platform validation, clinical progress, and the ability to create differentiated oncology assets.
バイオ業界での位置付け
Immunome is a platform oncology name whose valuation is sensitive to translational and strategic progress.
今後のカタリスト
- Immunome’s catalysts are its antibody-discovery platform and oncology pipeline, especially any update that shows the company can still produce differentiated assets. The next readout matters because the platform still needs to prove itself.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。